Editorial
doi: 10.2337/dc09-0374.
Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future
- PMID: 19794002
- PMCID: PMC2752911
- DOI: 10.2337/dc09-0374
Item in Clipboard
Editorial
Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future
Diabetes Care.
2009 Oct.
No abstract available
Figures
Natural history of type 1 diabetes and prevention opportunities.
Comment on
-
Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside.Diabetes Care. 2009 Oct;32(10):1753-68. doi: 10.2337/dc09-0373. Diabetes Care. 2009. PMID: 19794001 Free PMC article. No abstract available.
Similar articles
-
Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside.Diabetes Care. 2009 Oct;32(10):1753-68. doi: 10.2337/dc09-0373. Diabetes Care. 2009. PMID: 19794001 Free PMC article. No abstract available.
-
Antigen-based therapy for the treatment of type 1 diabetes.Diabetes. 2009 Sep;58(9):1939-46. doi: 10.2337/db09-0451. Diabetes. 2009. PMID: 19720821 Free PMC article. No abstract available.
-
Immune modulation for prevention of type 1 diabetes mellitus.Trends Biotechnol. 2005 Mar;23(3):128-34. doi: 10.1016/j.tibtech.2005.01.009. Trends Biotechnol. 2005. PMID: 15734555 Review.
-
Immunomodulatory therapy of human type 1 diabetes: lessons from the mouse.J Clin Invest. 2001 Jul;108(1):31-3. doi: 10.1172/JCI13445. J Clin Invest. 2001. PMID: 11435453 Free PMC article. No abstract available.
-
Type 1 diabetes vaccine development: animal models vs. humans.Hum Vaccin. 2011 Jan 1;7(1):19-26. doi: 10.4161/hv.7.1.12641. Epub 2011 Jan 1. Hum Vaccin. 2011. PMID: 21157185 Review.
Cited by
-
Abnormal T Cell Frequencies, Including Cytomegalovirus-Associated Expansions, Distinguish Seroconverted Subjects at Risk for Type 1 Diabetes.Front Immunol. 2018 Oct 22;9:2332. doi: 10.3389/fimmu.2018.02332. eCollection 2018. Front Immunol. 2018. PMID: 30405601 Free PMC article.
-
Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.Nat Rev Drug Discov. 2011 Jun;10(6):439-52. doi: 10.1038/nrd3402. Nat Rev Drug Discov. 2011. PMID: 21629294 Review.
-
Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation.Rheum Dis Clin North Am. 2010 May;36(2):213-41. doi: 10.1016/j.rdc.2010.02.001. Rheum Dis Clin North Am. 2010. PMID: 20510231 Free PMC article. Review.
-
Hypoglycaemic activity of Commelina africana and Ageratum conyzoides in relation to their mineral composition.Afr Health Sci. 2012 Jun;12(2):198-203. doi: 10.4314/ahs.v12i2.19. Afr Health Sci. 2012. PMID: 23056028 Free PMC article.
-
Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.Clin Exp Immunol. 2013 Jan;171(1):82-90. doi: 10.1111/j.1365-2249.2012.04675.x. Clin Exp Immunol. 2013. PMID: 23199327 Free PMC article.
References
-
- Rewers M, Norris J, Kretowski A: Epidemiology of type 1 diabetes mellitus. In Type 1 Diabetes: Cellular, Molecular & Clinical Immunology. Eisenbarth GS. Ed. Online edition, version 3.0. Available from http://www.uchsc.edu/misc/diabetes/books/type1/type1_ch9.html. Accessed 15 January 2009
-
- Diabetes Epidemiology Research International Group. Secular trends in incidence of childhood IDDM in 10 countries. Diabetes 1990;39:858–864 - PubMed
-
- Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, Laporte R, Tuomilehto J: Incidence of childhood type 1 diabetes worldwide: Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000;23:1516–1526 - PubMed
-
- Harjutsalo V, Sjoberg L, Tuomilehto J: Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008;371:1777–1782 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
